Alyeska Investment Group
MGNX icon

Alyeska Investment Group’s MacroGenics MGNX Stock Holding History

Alyeska Investment Group’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-100,000
Closed -$1.6M – 635
2021
Q4 		$1.6M Buy
+100,000
New +$1.88M 0.02% 472
2018
Q2 		– Sell
-150,000
Closed -$3.77M – 500
2018
Q1 		$3.77M Buy
+150,000
New +$3.64M 0.03% 310
2014
Q4 		– Sell
-10,435
Closed -$218K – 519
2014
Q3 		$218K Sell
10,435
-60,685
-85% -$1.26M ﹤0.01% 370
2014
Q2 		$1.54M Buy
71,120
+9,870
+16% +$207K 0.03% 331
2014
Q1 		$1.71M Buy
61,250
+11,250
+23% +$397K 0.05% 271
2013
Q4 		$1.37M Buy
+50,000
New +$1.31M 0.05% 252

Other funds holding MGNX

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Alyeska Investment Group's MGNX Position: Q1 2022 in Review

Alyeska Investment Group sold out of MacroGenics (MGNX) in Q1 2022, closing a stake of 100,000 shares — an estimated $1.6M sold.

Alyeska Investment Group first reported a position in MGNX in Q4 2013 and held it in 6 quarters. The position peaked at $3.77M in Q1 2018. 144 funds tracked by Wall St. Rank hold MGNX as of Q1 2022.

  • Alyeska Investment Group reported no remaining MacroGenics position as of Q1 2022 after selling out during the quarter.
  • Alyeska Investment Group sold 100,000 MacroGenics shares in Q1 2022, an estimated $1.6M.
  • Alyeska Investment Group first reported a position in MacroGenics in Q4 2013 and held it in 6 quarters.
  • Alyeska Investment Group's MacroGenics position peaked at $3.77M in Q1 2018.
  • 144 funds tracked by Wall St. Rank held MacroGenics as of Q1 2022.

Based on Alyeska Investment Group's 13F filing for Q1 2022, filed 16 May 2022.